Loading
Max Healthcare Institute Limited Stock: price and insider trades · India
No insider purchase over the last 90 days. The latest, by Manpreet Singh Sohal, was filed 21 Sept 2021.
Insider Decl.
111
Thresholds
n/a
Buy Volume
€61,845
1 ops. · all time
Sell Volume
€2B
21 ops. · all time
Since the insiders bought
- +14.8%Entry ₹371.90 · Close at T+365 ₹426.80
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analyst consensus: bullish or bearish?
Analysts rate Max Healthcare Institute Limited Buy (bullish), based on 26 analysts. Average price target: ₹1,153.69.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 12,052 of 26,280 companies
53.6
score / 100
Value30
Quality77
FCF yld0.2%
Earn yld1.8%
EV/EBITDA36.1x
ROE14%
Gross mgn78%
Net mgn18%
Debt/EBITDA1.5x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2026FY ended March 2026 · cache
₹830.00
Analyst consensus
26 analystsBuy
₹825.00Target ₹1,153.69(+39%)₹1,320.00
Income statement
Revenue₹82.3B
Gross profit₹64.4B78% margin
EBITDA₹23.4B28% margin
Net income₹14.4B16.7% margin
Valuation
PER (trailing)55.7x
PER (forward)35.6x
P/Book7.5x
Beta0.10
Balance sheet & cash
Market cap₹807.8B
Total debt₹34.8B
Free Cash Flow₹1.5B
Debt / Equity32%
Profitability & ownership
ROE14.3%
ROA6.9%
% insiders28.2%
% institutions59.9%
Last declaration on 26 August 2022
Declarations111 total
6,874,447 shares100.0% of flowEquity SharesSEBI:85f7e4d3da1f6f44d8fa7f7e8cf6dcda957760c1
6,874,447 shares0.0% of flowEquity SharesSEBI:5c006a206c77d6c2c720d8e70b6a88c7401d9570
260,196,762 shares@ ₹353.033638.8% of flowEquity SharesSEBI:0e189cd68b61b910eafd8dda937f575d332cb8b1
96,958,852 shares@ ₹340.022313.4% of flowEquity SharesSEBI:a2676493f757e2f0072a82f5350a06f513228d91
13,000 shares@ ₹405.0010.7% of flowEquity SharesSEBI:e58b9ae25cc36ed5064e2117c59a2948fb98999e
84,722 shares@ ₹399.4097.5% of flowEquity SharesSEBI:eadfaf1e6b0646ff67b575ee310fcb43377cded4
17,000 shares@ ₹399.9548.0% of flowEquity SharesSEBI:fb8ca0211cec5691c0087d094cc4e6a95ab44e10
3,985 shares@ ₹399.0025.7% of flowEquity SharesSEBI:c6a46dd5c928a8790c87d3ae4e96365cab48417f
4,000 shares@ ₹397.5022.7% of flowEquity SharesSEBI:b5bb187a236ae7db6bd23a2f7923a70372c57621
25,749 shares@ ₹400.0021.0% of flowEquity SharesSEBI:42a331137b2d6a9b2592169db012d7526e21c1d5
22,262 shares@ ₹397.10515.1% of flowEquity SharesSEBI:ead1a521bff3d9c50839771cbb0aeda6f8908220
5,000 shares@ ₹380.8984.7% of flowEquity SharesSEBI:cba7ffb367ee948ade8839289201cabf14df8486
30,000 shares@ ₹393.043358.5% of flowEquity SharesSEBI:3a504e0d12b6f19348427eb0da4fd6333101b672
32,527 shares@ ₹382.576451.4% of flowEquity SharesSEBI:c557c399acd63c9e06250278b12c9f5a08dea746
35,143 shares@ ₹379.0022.9% of flowEquity SharesSEBI:20b8ddcdcf4dc805f61712bd716f9bae8fc33920
5,432 shares@ ₹378.00073.5% of flowEquity SharesSEBI:6040324833b47de68ec8d04a0815f7db1a974894
5,000 shares@ ₹377.0085.5% of flowEquity SharesSEBI:28960c3180536bbc7cd4746bd735e02a5a3bb9b0
84,722 shares@ ₹10.002.5% of flowEquity SharesSEBI:042c979c8e1eb3179ead57500c2963787d019570
31,963 shares@ ₹380.2097.5% of flowEquity SharesSEBI:ccae5aa1be05b99c89beb5aa346c6695133d7b8a
15,685 shares@ ₹378.711510.2% of flowEquity SharesSEBI:98b05eebf7ba6e66b1342d1a49616afa932dfda4
39,310 shares@ ₹10.00100.0% of flowEquity SharesSEBI:2edeb7d2b166f8b12d133db4e6fc0f253b25d91a
33,681 shares@ ₹10.00100.0% of flowEquity SharesSEBI:f51ee3b12cad0cdf84315bc71f92f8748e0b7f0b
45,143 shares@ ₹367.34432.8% of flowEquity SharesSEBI:5670c29e482965e7b1bf9dece760978841189521
21,435 shares@ ₹374.994297.4% of flowEquity SharesSEBI:8faa921a5c99f2716681f9abc2f6bdbc0fd2e4c8
25,075 shares@ ₹373.2597.4% of flowEquity SharesSEBI:ac5290b93ca89a7b6858965fe5d5e85d04278b61
25 of 111 declarations
About Max Healthcare Institute Limited
Max Healthcare Institute Limited, an Indian health care group listed on the Bombay Stock Exchange, has a market capitalisation of INR 807.8 billion, with 28.2% of the capital held by insiders. Its record counts 109 filings from 57 filers, published between June 23, 2021 and August 26, 2022, almost all in 2021: 105 against 4 in 2022.
There are 21 sales, 3 of them filed by Kayak Investments Holding Pte. Ltd., which has 8 filings in all. The median sale is EUR 61,522. The only purchase in the record, EUR 61,845, is by Manpreet Singh Sohal on September 16, 2021. The record also holds 48 grants and 39 filings of another kind.
Read moreShow less
Sandeep Dogra filed 6, 1 of them a sale, Ruchi Mahajan 3 with 2 sales, and Nidhi M Dev 3 with 1 sale. Filings are published 2 days after the trade at the median, and none falls within the last twelve months.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
